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Histone acetylation plays an important role in chromatin remodeling and transcription control. Acetylation of histones is regulated by
histone acetyltransferases and histone deacetylases (HDACs). Human papillomavirus type 16 (HPV16) E7 can inactivate retinoblastoma
protein (pRB), which recruits histone deacetylases, and also physically interacts with histone acetyltransferases and histone deacetylases,
suggesting E7 may affect histone acetylation. To test this, we have analyzed the state of acetylation of histone H3 in human foreskin
keratinocytes. HPV16 E7 increased acetylation of histone H3 on lysine 9, which is related to transcription activation. The ability to bind both
pRB and histone deacetylase was required for HPV16 E7 to increase histone acetylation. Chromatin immunoprecipitations showed HPV16
E7 increases histone acetylation on the E2F1 and cdc25A promoters. Consistent with this, RT-PCR analysis showed an increase in the
expression of E2F-responsive genes involved in cell cycle control. HPV16 E7 affected neither the steady-state levels of histone
acetyltransferases or deacetylases nor histone deacetylase activity. However, HPV16 E7 did increase the level of methylation of histone H3
on lysine 4, which normally requires displacement of histone deacetylase. In contrast, sodium butyrate, a known inhibitor of histone
deacetylases, caused an increase in acetylated but not methylated histone H3. These data suggest HPV16 E7, by increasing histone
acetylation, may create a transcriptionally active chromatin structure to promote expression of genes vital for cell cycle progression.
D 2004 Elsevier Inc. All rights reserved.
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Human papillomaviruses (HPVs) are small, double-
stranded DNA viruses. HPVs can be subdivided into two
groups based upon the disease they cause after infection. The
low-risk viruses have been associated with benign prolifer-
ative lesions while high-risk viruses increase the risk of
development of malignant tumors. (Burd, 2003; Einstein and
Goldberg, 2002; Ponten and Guo, 1998; Shen et al., 1995).
HPV type 16 (HPV16) is the most common high-risk HPV0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2004.08.009
* Corresponding author. Department of Microbiology and Immunol-
ogy, Indiana University School of Medicine, 635 Barnhill Drive, Indian-
apolis, IN 46202-5120. Fax: +1 317 274 4090.
E-mail address: aroman@iupui.edu (A. Roman).
1 Current address: Department of Biochemistry and Biophysics,
University of North Carolina, Chapel Hill, NC 27599-7260.and is highly associated with cervical cancers (zur Hausen,
1996). The HPV16 genome encodes three oncoproteins, E5,
E6, and E7. E5 is a weak oncoprotein that enhances EGFR-
mediated signal transduction (Crusius et al., 1998; Straight et
al., 1993; Zhang et al., 2002). E6 is known to bind the tumor
suppressor p53 and target it for degradation (Scheffner et al.,
1990; Thomas et al., 1999; Werness et al., 1990). E7 is the
major transforming protein in HPV (Munger et al., 2001;
Vousden, 1993). HPV16 E7 can immortalize human epithe-
lial cells (Halbert et al., 1991) and abrogate growth arrest
signals mediated by DNA damage and differentiation
conditions (Demers et al., 1996; Song et al., 1998). HPV16
E6 and E7 cooperate to immortalize human foreskin
keratinocytes (HFKs) (Hawley-Nelson et al., 1989; Munger
et al., 1989a).
The oncogenicity of HPV16 E7 is partially attributable to
its ability to inactivate the retinoblastoma protein (pRB) that04) 189–198
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E2F and represses transcription (Helt and Galloway, 2001;
Munger and Phelps, 1993; Weintraub et al., 1992; Wu et al.,
1993). E7 binds pRB and targets it for degradation
(Gonzalez et al., 2001; Munger et al., 1992). This allows
E2F to transactivate the E2F-responsive genes required for
entry into S-phase (Lam et al., 1994; Nguyen et al., 2002).
However, inactivation of pRB by HPV16 E7 is necessary
but not sufficient to deregulate cell cycle control (Brehm et
al., 1999; Helt and Galloway, 2001). An intact C-terminus
portion of E7 is also important for its ability to bypass
differentiation and p21-mediated growth arrest (Helt et al.,
2002). Loss of E7–histone deacetylase (HDAC) interaction,
which is mediated by the C-terminus of E7, results in a
defect in the transforming activity of E7 and its ability to
overcome pRB-mediated growth arrest (Brehm et al., 1999;
Phelps et al., 1992). These data suggest E7 protein has
multiple activities that contribute to its oncogenicity.
Histone modifications, including acetylation, methyla-
tion, and phosphorylation, play determining roles in
chromatin structure and transcription factor accessibility
(Li et al., 2002b; Orlando and Jones, 2002; Yamamoto et al.,
2003; Zhang and Reinberg, 2001). HPV16 E7 interacts with
HDACs via Mi2h and with histone acetylases (HATs) and
therefore has the potential to alter the level of histone
acetylation (Avvakumov et al., 2003; Bernat et al., 2003;
Brehm et al., 1999; Huang and McCance, 2002). In addition
to binding the transactivation domain of E2F, pRB can
repress transcription of E2F-mediated promoters by recruit-
ing histone deacetylases (HDACs) and affecting chromatin
remodeling (Brehm et al., 1998, 1999; Ferreira et al., 2001;
Luo et al., 1998). Therefore, inactivation of pRB by E7 may
also indirectly affect HDAC activity and, in turn, histone
acetylation and chromatin remodeling.
Experiments reported here were designed to test the
hypothesis that E7 affects the level of acetylation of cellular
histones. We found that HPV16 E7 increased acetylation of
histone H3 on lysine 9 in HFKs. Methylation of histone H3
on lysine 4, which is related to transcription activation, was
also increased. Chromatin immunoprecipitation analysis
showed HPV16 E7 increased the acetylation of histones
on the promoters of two E2F-responsive genes, E2F1 and
cdc25A. Analysis of E7 mutants C24G, L67R, and S71C
showed that both E7–pRB binding and E7–HDAC inter-
actions are required for E7 to increase histone acetylation
and methylation.Fig. 1. HPV16 E7 increases the acetylation of histone H3 in HFKs. HFKs
were infected with control retrovirus LXSN or L(16E7)SN encoding
HPV16 E7 protein and were grown in C-K-SFM or C-K-SFM containing
12.5 AM roscovitine for 48 h. Acid extracts were prepared and analyzed by
Western blot sequentially with antibodies to acetylated histone H3 (AcH3),
acetylated histone H3 K9 (AcH3-K9), and total histone H3.Results
HPV16 E7 increases the acetylation of histone H3
To determine the effect of HPV16 E7 on histone
acetylation levels, HFKs were infected with parental
retrovirus LXSN or retrovirus L(16E7)SN that encodes
wild-type HPV16 E7. Infected cells were grown in completekeratinocyte serum-free media (C-K-SFM) to 80% con-
fluence and E7 expression was verified by Northern blot and
Western blot (data not shown). The acetylated state of
histones in the transduced HFKs was determined by
Western blot using antibody to acetylated histone H3 and
histone H3 acetylated on lysine 9 (K9). The same blot was
also probed with antibody to total histone H3. Acetylation
of histone H3 K9 was significantly increased in HPV16 E7-
expressing cells (Fig. 1). To investigate whether the increase
in histone H3 acetylation is the result of an increased
number of E7-expressing cells in S-phase, infected cells
were grown in C-K-SFM containing 12.5 AM roscovitine, a
cdk inhibitor, for 48 h (Nguyen et al., 2002). FACS analysis
showed both control cells and E7-expressing cells were
growth arrested (data not shown). Acid extracts of these
cells were analyzed by Western blot using the above-
mentioned antibodies. E7 increased histone H3 acetylation
in both normal growth conditions and growth-arrested
conditions (Fig. 1).
HPV16 E7 increases histone acetylation on E2F1 and
cdc25A promoters
To test whether HPV16 E7 increases histone acetylation
on E2F1 and cdc25A promoters, two E2F-responsive
promoters, chromatin immunoprecipitation analysis was
performed. Chromatin was extracted from cells and cleaved
by sonication. DNA fragments associated with acetylated
histone H3 were precipitated with antibody to acetylated
histone H3. After immunoprecipitation, DNA bound to
acetylated histone H3 was purified and detected by PCR
using primers that amplify from 102 to +2 of the E2F1
promoter and from 120 to +40 of the cdc25A promoter.
Histone H3 acetylation of the E2F1 promoter was signifi-
cantly increased in cells expressing HPV16 E7 (Fig. 2A).
Similarly, an increase of acetylated histone H3 on the
cdc25A promoter was observed (Fig. 2B). PCR was also
conducted on the above samples using primers amplifying
the promoter region of pS2, an estrogen-regulated gene
Fig. 2. Chromatin immunoprecipitation shows HPV16 E7 increases the
acetylation of histones on the E2F1 and cdc25A promoters. Chromatin was
extracted from cells infected with LXSN or L(16E7)SN and cleaved by
sonication. Acetylated histone H3-associated DNA fragments were
precipitated with antibody to acetylated histone H3. After immunoprecipi-
tation, DNA bound to acetylated histone H3 was purified and analyzed by
PCR to detect the E2F1 (A), cdc25A (B), and pS2 promoter (C).
Fig. 3. Expression of E2F-responsive genes is increased in HFKs
expressing HPV16 E7. Total RNA was extracted from HFKs infected with
LXSN or L(16E7)SN. RNA was analyzed by RT-PCR with primers
amplifying E2F1, cdc25A, DHFR, p107, and GAPDH. The PCR products
were visualized on a 2% agarose gel. Densitometric quantitation of PCR
products was adjusted to an equal amount of DNA for the PCR between
LXSN- and L(16E7)SN- infected cells using GAPDH.
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acetylation on the pS2 promoter (Fig. 2C).
Expression of endogenous E2F-responsive genes is
increased in HFKs expressing HPV16 E7
Histone acetylation is related to transcription activation
(Nishioka et al., 2002; Zhang and Reinberg, 2001).
Increased levels of acetylated histones on E2F-responsive
promoters would suggest increased levels of expression of
endogenous E2F-responsive genes. To test this, total RNA
was extracted from control virus-infected cells and cells
infected with retrovirus L(16E7)SN. RNAwas amplified by
RT-PCR with primers to E2F1, cdc25A, DHFR, and p107.
GAPDH amplification served as an internal control. The
amplified product was visualized on a 2% agarose gel.
Expression of different genes was quantitated by densitom-
etry and the relative levels of expression in the HPV16 E7
cells corrected for the presence of differences in input RNA,
based on the GAPDH result. The results showed thatexpression of E2F1, cdc25A, DHFR, and p107 genes was
increased 2.6- to 4.7-fold in HFKs expressing E7 compared
to control cells (Fig. 3). These results extend an earlier
report showing increased transcription of endogenous
cdc25A in E7-expressing cells (Nguyen et al., 2002).
Increased histone acetylation requires binding of E7 to both
pRB and HDAC
The mechanism by which E7 affects histone H3
acetylation may be related to the interaction of E7 with
HDAC (Brehm et al., 1999). Because pRB also recruits
HDAC activity (Brehm et al., 1998, 1999; Ferreira et al.,
2001; Lai et al., 2001; Luo et al., 1998), the E7 targeting of
pRB for degradation may be another way to affect histone
acetylation. To determine which activity of E7 was required
to alter histone H3 acetylation, retroviruses encoding E7
mutated on either C24 that is required to bind pRB, L67 that
is required to bind HDAC, or S71 that does not affect the
ability of E7 to bind either HDAC or pRB were generated
(Brehm et al., 1999). HFKs were infected with control virus
LXSN, retrovirus L(16E7)SN that contained wild-type E7,
or L(L67R)SN, L(C24G)SN, and L(S71C)SN that encoded
the mutated E7 proteins. The E7 mutants are stably
expressed in mammalian cells (Demers et al., 1996; Nguyen
et al., 2002; Phelps et al., 1992; and data not shown).
Infected cells were grown in C-K-SFM to 80% confluence.
Acid extracts were analyzed by Western blot using anti-
bodies to acetylated histone H3 K9. The same blot was
reprobed with antibodies to total histone H3. Results
showed that loss of the ability of E7 to bind either HDAC
or pRB caused a loss of the ability of E7 to increase histone
acetylation (Fig. 4). In contrast, the S71C mutant that retains
the ability to bind HDAC and pRB was able to increase
Fig. 4. The ability of HPV16 E7 to increase the acetylation and methylation
of histone H3 is dependent upon E7 binding both pRB and HDAC. HFKs
were infected with parental virus LXSN or retrovirus encoding wild-type
HPV16 E7 or E7 mutated at C24, L67, or S71. Acid extracts were analyzed
by Western blot with antibodies to acetylated histone H3 (AcH3), acetylated
histone H3 K9 (AcH3-K9), methylated histone H3 K4 (MeH3-K4), and
total histone H3.
Fig. 5. HPV16 E7 does not affect HAT and HDAC steady-state levels.
HFKs were infected with control retrovirus LXSN or L(16E7)SN encoding
HPV16 E7. Whole cell lysates were analyzed by Western blot with
antibodies to (A) HATs: p/CAF, CBP, and p300; and (B) HDACs: HDAC1
and HDAC2.
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binding of E7 to both pRB and HDAC is required to
increase histone acetylation.
HAT and HDAC steady-state levels are not affected by E7
and E7 does not affect HDAC activity in HFKs
Histone H3 acetylation is regulated by HATs and HDACs
(Li et al., 2002b; Zhang and Reinberg, 2001). HPV16 E7
may affect histone H3 acetylation through affecting the
steady-state level of HAT or HDAC. Therefore, experiments
were conducted to determine whether HPV16 E7 affected
the steady-state levels of HATs and HDACs or the activity
of HDAC in HFKs.
To test whether HPV16 E7 affects the steady level of
HATs and HDACs, HFKs were infected with LXSN or
L(16E7)SN retrovirus and grown in C-K-SFM to 80%
confluence, and whole cell lysates were analyzed using
antibodies to p/CAF, CBP, and p300, members of the HAT
family, or to HDAC1 and HDAC2, members of HDAC
family, shown to bind HPV16 E7 (Avvakumov et al., 2003;
Bernat et al., 2003; Brehm et al., 1999; Huang and
McCance, 2002). The results showed that E7 did not
significantly affect the steady-state levels of HATs or
HDACs (Fig. 5).
Two different approaches were taken to determine
whether HPV16 E7 could affect HDAC activity. In the first
approach, HDAC was immunoprecipitated from uninfected
HFK lysates using antibody to Mi2h because E7 binds
HDAC1/2 through Mi2h (Brehm et al., 1999). The immune
complexes (containing Mi2h associated with HDAC) were
incubated with increasing amounts of GST or GST-16E7
and, following washing, with [3H]acetyl histone H4 peptide.
Each sample was assayed for released [3H]acetate. Normal
rabbit IgG was used for immunoprecipitation in a parallel
assay as a negative control. Sodium butyrate (NaBut), an
HDAC inhibitor, was used to demonstrate the specificity of
deacetylation. In parallel, immune complexes, incubatedwith the same amount of GST and GST-16E7 and then
washed, were subjected to Western blot to determine
whether E7 bound to the complex. The results showed E7
but not GST bound to Mi2h but did not affect Mi2h-
associated HDAC activity significantly (Figs. 6A and B). In
the second approach, HDAC2 was immunoprecipitated from
lysates of control virus LXSN-infected cells or cells infected
with L(16E7)SN. The immune complexes were incubated
with [3H]acetyl histone H4 peptide and each sample was
assayed for released [3H]acetate. Consistent with the first
approach, E7 did not affect the HDAC activity in this assay
(Fig. 6C).
HPV16 E7 increases histone H3 methylation; the activity
requires binding of E7 to both pRB and HDAC
Methylation of histone H3 on lysine 4 (K4) is another
indicator of transcriptionally active chromatin (Nishioka et
al., 2002; Zhang and Reinberg, 2001). Methylation of
histone H3 K4 is related to acetylation of histone H3 (Noma
and Grewal, 2002; Nishioka et al., 2002). Therefore, we
tested whether HPV16 E7 also caused an increase in histone
H3 methylation. The same blot shown in Fig. 4 was
analyzed with antibodies to methylated histone H3 K4.
HPV16 E7 increased methylation of histone H3 K4
consistent with its effect on acetylation of histone H3 K9
(Fig. 4). Similar to the amino acids of HPV16 E7 required
for increased acetylation of histone H3, increased methyl-
ation of histone H3 K4 required C24 and L67 (Fig. 4).
Both HPV16 E7 and sodium butyrate increase acetylation of
histone H3 K9 but only HPV16 E7 increases methylation of
histone H3 K4
Because sodium butyrate is a strong inhibitor of HDAC,
Western blot analysis was performed to compare the effect
of HPV16 E7 and sodium butyrate on histone H3 K9
acetylation and K4 methylation. HFKs infected with
retrovirus LXSN or L(16E7)SN were grown in C-K-SFM
with a parallel plate of LXSN-infected cells treated with 2.5
mM sodium butyrate for 48 h. Acid extracts were prepared
Fig. 6. E7 does not affect HDAC activity significantly. (A) HDAC-containing immune complexes were immunoprecipitated from whole cell lysates from
uninfected HFKs using anti-Mi2h (E7 binds HDAC via Mi2h). The immunoprecipitates were incubated with GST or GST-16E7 and then washed with HDAC
buffer. The complexes were incubated with [3H]acetyl histone H4 peptide and the supernatants assayed for released [3H]acetate. (B) A parallel
immunoprecipitation was done as described in A. The immunoprecipitates were incubated with GST or GST-16E7 C and washed with HDAC buffer. The
samples were then analyzed by Western blot using antibody to GST. (C) HDAC2 was immunoprecipitated from whole cell lysates from HFKs infected with
LXSN or L(16E7)SN using antibody to HDAC2. The immunoprecipitates were incubated with [3H]acetyl histone H4 peptide and the supernatants assayed for
released [3H]acetate.
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methylated histone H3 K4, and total histone H3. Both
HPV16 E7 and sodium butyrate increased acetylation of
histone H3 K9 but only E7 increased methylation of histone
H3 K4 (Fig. 7).Discussion
In eukaryotic cells, DNA is complexed with core
histones and other chromosomal proteins to form chromatin.
The nucleosome, the basic repeating unit of chromatin,
contains the four core histones H2A, H2B, H3, and H4wrapped with 146 bp of DNA (Kornberg and Lorch, 1999;
Zhang and Reinberg, 2001). The core histone tails are
required for nucleosome–nucleosome interaction (Luger et
al., 1997) and to establish transcriptionally active chromatin
(Grunstein et al., 1995; Zhang and Reinberg, 2001).
Modifications, including acetylation, methylation, and
phosphorylation, on the core histone tails play determining
roles in chromatin structure and transcription factor acces-
sibility, and thereby regulate gene expression (Zhang and
Reinberg, 2001). Histone acetylation is one important step
in chromatin remodeling because it produces a weakened
interaction between histone and DNA leading to a more
dynamic chromatin structure for transcription factors to
Fig. 7. Both HPV16 E7 and sodium butyrate (an HDAC inhibitor) increase
acetylation of histone H3 K9 but only E7 increases methylation of histone
H3 K4. HFKs were infected with control retrovirus LXSN or L(16E7)SN.
The cells were grown in C-K-SFM and a parallel plate of LXSN infected
cells was treated with 2.5 mM NaBut for 48 h. Acid extracts were prepared
and analyzed by Western blot using antibodies to acetylated histone H3 K9
(AcH3-K9), methylated histone H3 K4 (MeH3-K4), and total histone H3.
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deacetylation leads to a tightened chromatin structure that
represses transcription (Orlando and Jones, 2002).
HPV16 E7 encodes a 98 amino acid protein that is
structurally and functionally homologous to adenovirus
E1A and simian virus 40 large T antigen (Barbosa et al.,
1990; Chellappan et al., 1992). The E7 protein can be
divided into three domains, CR1 (amino acids 2–15), CR2
(amino acids 16–38), and the C-terminal zinc finger domain
(amino acids 39–98). Functionally, the CR2 domain
contains the LXCXE motif that is responsible for the
interaction with pRB and contributes to the ability of E7 to
transform human keratinocytes (Munger et al., 1989b). The
C-terminal zinc finger region interacts with HDAC1/2
through Mi2h, a component of the NuRD complex, and is
indispensable for the transforming activity of HPV16 E7
(Brehm et al., 1999; Phelps et al., 1992). HPV16 E7 also
interacts with HATs (p/CAF and p300) and reduces their
activity (Avvakumov et al., 2003; Bernat et al., 2003; Huang
and McCance, 2002).
The results reported here show for the first time that
histone H3 acetylation is increased in human foreskin
keratinocytes expressing HPV16 E7 (Fig. 1). E7 increased
histone H3 acetylation even in growth-arrested cells,
indicating that the increase in histone H3 acetylation by
E7 is independent of cell cycle progression (Fig. 1). We
also showed that increased levels of acetylation of histone
H3 are specifically associated with E2F-mediated pro-
moters that are activated in these cells (Figs. 2 and 3).
Analysis of the modification of specific amino acids on
histone H3 revealed that HPV16 E7 increases the
acetylation on K9 and also methylation on K4 (Figs. 1
and 4), both of which are related to transcription
activation (Nishioka et al., 2002; Zhang and Reinberg,
2001). Mutational analysis, using E7 mutated at C24,
which results in loss of pRB binding activity, or L67,
which results in loss of the ability to interact with HDAC,
showed that the increase of histone acetylation by HPV16
E7 requires both binding to pRB and interaction with
HDAC. Increased methylation of histone H3 K4 is also
lost with these two mutants (Fig. 4). In contrast, anotherE7 mutant S71C, which retains the ability to bind HDAC
and pRB, can efficiently increase histone H3 K9
acetylation and K4 methylation (Fig. 4). Neither HPV16
E7 C24G nor L67R can induce expression of endogenous
cdc25A (Nguyen et al., 2002). Cells expressing wild-type
HPV16 E7 or the S71C E7 mutant can bypass pRB-
mediated growth arrest in Saos2 cells or serum starvation-
induced growth arrest in NIH 3T3 cells, but the C24G
and L67R E7 mutants have lost these activities (Brehm et
al., 1999; Nguyen et al., 2002). Similarly, we have found
that wild-type E7 and the S71C mutant can increase the
percentage of HFKs in S-phase, but C24G and L67R
cannot (data not shown). Hence, the ability of HPV16 E7
to increase histone acetylation correlates with its ability to
activate E2F-responsive genes and increase S-phase entry,
all of which require E7–HDAC interaction and E7–pRB
binding. Interestingly, it has recently been shown that, for
HPV 31, binding of E7 to both HDAC and pRB is also
required to extend the life span of human foreskin
keratinocytes (Longworth and Laimins, 2004). Histone
H3 acetylation on K9 is increased on E2F-responsive
promoters at the G1-S transition (Nicolas et al., 2003) and
methylation of histone H3 K4 plays a role in the
maintenance of transcriptionally active chromatin through-
out the cell cycle (Noma and Grewal, 2002). The ability
of E7 to increase histone H3 acetylation on K9 and
histone H3 methylation on K4, both of which are related
to transcription activation, may contribute to its ability to
increase S-phase entry, bypass growth arrest, and extend
the cellular life span (Nishioka et al., 2002; Zhang and
Reinberg, 2001).
Either an increase of HAT steady-state level or activity,
or an inhibition of HDAC steady-state level or activity,
will lead to increased histone acetylation (Kuo and Allis,
1998). HPV16 E7 has been shown to interact with HATs
and HDACs (Avvakumov et al., 2003; Bernat et al., 2003;
Brehm et al., 1999; Huang and McCance, 2002). HPV16
E7 does not affect the steady levels of HATs and HDACs
(Fig. 5). Others have shown that E7 reduces HAT activity
(Avvakumov et al., 2003; Bernat et al., 2003; Huang and
McCance, 2002). This would not explain the phenomenon
we observed. Our HDAC activity assay results suggest
HPV16 E7 does not affect HDAC activity (Fig. 6). As
discussed above, the ability of HPV16 E7 to increase
acetylation of histone H3 requires that E7 both bind pRB
and interact with HDAC. The complex formed between the
L67R E7 mutant and pRB does not appear to contain
either HDAC 1 or 2 (Brehm et al., 1999, Longworth and
Laimins, 2004). However, even if E7 can dissociate
HDACs from pRB, this alone does not result in increased
histone acetylation. Perhaps a second repressive complex,
the NuRD complex, remains constitutively associated with
the chromatin (Li et al., 2002a), and interference with the
function of HDAC by binding of E7 to Mi2h is critical to
blocking accessibility of HDAC to its substrate (Brehm et
al., 1999). This is supported by the fact that sodium
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H3 K9 acetylation but E7 increases both histone H3 K9
acetylation and histone H3 K4 methylation (Fig. 7).
Methylation of histone H3 K4 normally results from the
displacement of the HDAC complex, because the respon-
sible histone H3 methyltransferase (HMT) competes with
HDAC to access its substrate, the N-terminal tail of
histone H3 (Nishioka et al., 2002). HPV16 E7, instead of
directly inhibiting HDAC activity, may displace HDAC
that causes an increase of histone acetylation and at the
same time may increase the accessibility of HMT to
histone H3 K4, which results in increased histone H3
methylation on K4.Materials and methods
Cell culture
HFKs were prepared as previous described (Zhang et al.,
2002) and were kept in complete keratinocyte serum-free
media (C-K-SFM): keratinocyte serum-free media supple-
mented with human recombinant epidermal growth factor
(EGF, Invitrogen) and bovine pituitary extract (BPE,
Invitrogen). Retrovirus packaging cell line PA317 and
Phoenix-ampho cells (ATCC) were grown in DMEM plus
10% fetal calf serum (FCS).
Retrovirus infection
Retrovirus infection was performed as previous
described (Zhang et al., 2002). Third passage HFKs were
grown to about 40% confluence in a 10-cm dish and
infected with 5 ml of the recombinant retrovirus or parental
virus (1  106 virus particles/ml) in the presence of 8 Ag/ml
of polybrene. After 6 h, the cells were fed with C-K-SFM
and kept in 37 8C, 5% CO2 for 48 h. Then the cells were
transferred to four 10-cm dishes and selected with G418
(200 Ag/ml) for 3–4 days. Selected cells were expanded and
used for experiments, generally at 80% confluence.
Acid extraction of histones
HFKs were grown in C-K-SFM to 80% confluence. The
cells were washed with cold PBS and scraped from the plate
into polypropylene eppendorf tubes. The cells were pelleted
by centrifugation at 200  g for 10 min, washed with cold
PBS, and resuspended in 10–15 volumes of lysis buffer (10
mM HEPES, pH 7.9, 1.5 mM MgCl2 and 10 mM KCl, 0.5
mMDTT, and 1.5 mM PMSF). Hydrochloric acid was added
to a final concentration of 0.2 M. After incubation on ice for
30 min, the sample was centrifuged at 11000  g for 10 min
at 4 8C. The supernatant was dialyzed with 200 ml 0.1 M
acetic acid twice for 1–2 h each, followed sequentially by
dialysis with 200 ml H2O for 1 h, 3 h, and overnight. The
protein was quantified and stored at 70 8C.Chromatin immunoprecipitation (ChIP) analysis
ChIP analysis was performed following the CHIPASSAY
KIT protocol (Upstate Biotechnology). Briefly, 1 106 cells
were cross-linked in 1% formaldehyde for 10 min. Cells
were washed with PBS, resuspended in 200 Al of CHIP/SDS
lysis buffer, and incubated on ice for 10 min. The cells were
then sonicated to shear the chromatin. The sonicated sample
was centrifuged and supernatant was transferred to a fresh
tube and mixed with 1.8 ml of ChIP dilution buffer. Forty
microliters of the sample was then transferred to another tube
as 2% input. The diluted supernatants were precleared with
50 Al of protein G (Upstate Biotechnology) for 30 min at 4
8C with rotation. After centrifugation, the protein G was
removed. Five micrograms of anti-acetylated histone H3
(Upstate Biotechnology) was added to the supernatants for
18 h at 4 8C with rotation. Fifty microliters of protein G was
then added to the sample and incubated for 1 h at 4 8C with
rotation. The immune complex was incubated with DNA
extraction buffer. Routine steps were performed to purify
the DNA bound to the immune complex. The purified
DNA was resuspended in 50 Al H2O and used in the
subsequent PCR analysis. PCR primers for the E2F1
promoter are 5V AGGAACCGCCGCCGTTGTTCCCGT,
3VCTGCCTGCAAAGTCCCGGCCACTT. PCR primers
for the cdc25A promoter are 5VAGCCTAGCTGCCAQ
TTCGGTTGAG, 3VAGCAGAAAACCAAGCCGACC.
PCR primers for the pS2 promoter are 5VGGCCATQ
CTCTCACTATGAATCACTTCTGC, 3VGGCAGGCTCQ
TGTTTGCTTAAAGAGCG. The PCR parameters were
94 8C for 5 min; 30 cycles of 94 8C for 30 s, 55 8C for
30 s, 72 8C for 30 s; followed by extension at 72 8C
for 7 min.
Semiquantitative RT-PCR
Total RNA was extracted from HFKs using Tri-Reagent
(Molecular Research Center), as previous described (Zhang
et al., 2002). RT-PCR was performed following the protocol
of the RT-PCR kit (Invitrogen). Briefly, 0.5 Ag of RNA
sample was digested with DNase I and incubated with
reverse transcriptase at 50 8C for 30 min. The sample was
then subjected to PCR with primers for E2F1, cdc25A,
DHFR, p107, and GAPDH (E2F1: 5VCTCGCAGATCGTCQ
ATCATCTC, 3VATGAGCTGGATGCCCTCAAG; cdc25A:
5VAGCCCCAAAGAGTCAACTAATCCAGA, 3VCCGGTQ
AGCTAGGGGGCTCACA; DHFR: 5VCAGAGAACTCQ
AAGGAACCTCCAC, 3VTTAATGCCTTTCTCCTCCTCQ
CAC; p107: 5VAGGAGCTGATCCAAATGCCTG,
3VTGGTGTCGCAAATGATGC; GAPDH: 5VGAAGGTQ
GAAGGTCGGAGTCA, 3VGAAGATGGTGATGGGATQ
TTC). PCR parameters were 94 8C for 5 min; 30 cycles
of 94 8C for 30 s, 55 8C for 30 s, 72 8C for 30 s;
followed by extension at 72 8C for 7 min. The amplified
DNA products were separated on a 2% agarose gel and
stained with ethidium bromide.
B. Zhang et al. / Virology 329 (2004) 189–198196HDAC assay
HDAC assay was performed with the HDAC assay kit
provided by Upstate Biotechnology. Histone H4 peptide was
labeled with [3H]acetyl-CoA (ICN) by recombinant p/CAF
(Upstate Biotechnology). HDAC was immunoprecipitated
from 500 Ag of whole cell lysates (from uninfected cells)
using anti-Mi2h [E7 binds HDAC via Mi2h (Brehm et al.,
1999)]. Immunoprecipitates were incubated with GST or
GST-16E7 for 2 h at 4 8C and washed with HDAC buffer (50
mM Tris–HCl pH 8.0, 150 mM NaCl, 10% Glycerol, 0.5%
Triton X-100). The complexes were then incubated with
40000 cpm of [3H]acetyl histone H4 peptide overnight at 37
8C. One hundred microliters of the supernatants was assayed
for released [3H]acetate. Normal rabbit IgG was used for
immunoprecipitation in a parallel assay as a negative control.
Sodium butyrate (250 mM, NaBut), an HDAC inhibitor, was
used to demonstrate the specificity of deacetylation. Immune
complexes from a parallel immunoprecipitation were also
incubated with same amount of GSTand GST-16E7 for 2 h at
4 8C. After washing in HDAC buffer, samples were subjected
to Western blot using antibodies to GST (Amersham ) to
determine whether E7 was bound to the complex. Alter-
natively, HDAC2 was immunoprecipitated from 500 Ag of
whole cell lysate from HFKs infected with LXSN or
L(16E7)SN using antibody to HDAC2 (Santa Cruz). The
immunoprecipitates were incubated with 40000 cpm of H4
peptide overnight at 37 8C. One hundred microliters of the
supernatants was assayed for released [3H]acetyl histone
[3H]acetate.
Western blot
Cell lysates were made using SDS lysis buffer (20 mM
Tris, pH 6.8, 1% SDS, 1 mM EDTA). Forty micrograms of
the acid extract (described above) or cell lysate was
separated by SDS-polyacrylamide gel electrophoresis
(SDS-PAGE). The protein was transferred to nitrocellulose
membrane. The membrane was blocked with 5% milk in
TBST for 1 h and probed with antibodies indicated in the
figures. The membrane was then washed three times and
incubated with secondary antibody conjugated with HRP for
1 h at room temperature. After washing five times with
TBST, the membrane was developed with ECL. Antibodies
to acetylated histone H3, acetylated histone H3 K9,
methylated histone H3 K4, p300, and CBP are from Upstate
Biotechnology. Antibodies to total histone H3 are from Cell
Signaling. Antibodies to HDAC1, HDAC2, and p/CAF are
from Santa Cruz Biotechnology, Inc., and to GADPH are
from Chemicon.
Immunoprecipitation
Five hundred micrograms of whole cell lysates prepared
with HDAC buffer (50 mM Tris–HCl pH 8.0, 150 mMNaCl,
10% Glycerol, 0.5% Triton X-100) was adjusted to 500 Aland was precleared by incubating with 40 Al of Protein-G-
agarose and 1 Ag normal rabbit IgG and rocking for 30 min.
After centrifugation for 30 s at 1000 g, the supernatant was
transferred to a fresh tube and incubated with 2 Ag of
appropriate antibody for 2 h. Forty microliters of Protein-G-
agarose was then added and the mixture rocked overnight at 4
8C. Immune complexes were collected by centrifugation and
washed three times with the HDAC buffer. Immunoprecipi-
tates were used for the HDAC assay as described above.Acknowledgments
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